Apr 20, 2026 | Alternative Reimbursement Strategies, Client Report, Compliance, MedBen Access, MedBen Employees, MedBen News, MedBen University, Pharmacy, Regulatory, Spending, Wellness
MedBen had a full house of employers and brokers in attendance at MedBen University’s (MBU) 25th annual Employer Roundtable on April 16 at the C. Arthur Morrow Conference Center in Newark, Ohio. Presented by MedBen’s team of industry experts, this year’s roundtable...
Apr 17, 2026 | Caroline Fraker, Centers for Medicare & Medicaid Services (CMS), Compliance, Department of Health and Human Services (HHS), Department of Labor, MedBen Employees, Mental Health Parity and Addiction Equity Act (MHPAEA), No Surprises Act (NSA), Regulatory, SPBA, TrumpRx
On March 30–31, MedBen President, COO & CPO Caroline Fraker attended the annual Society of Professional Benefits Administrators (SPBA) Spring Conference in Washington, D.C. Traditionally, this gathering of third-party administrator professionals focuses on...
Apr 16, 2026 | Announcements, Employer Dashboard, MedBen Analytics, Online Services, Reporting
As the May 1 launch of Multi-Factor Authentication (MFA) for the MedBen Analytics employer dashboard approaches, we’re providing additional guidance to help users prepare for the updated login experience. While MFA adds just a quick extra step, a few key details...
Apr 7, 2026 | Caroline Fraker, Centers for Medicare & Medicaid Services (CMS), Independent Dispute Resolution (IDR), No Surprises Act (NSA)
Employer plans are seeing a sharp rise in health care payment disputes under the No Surprises Act’s (NSA) independent dispute resolution (IDR) system. CMS data for the second quarter of 2025 show employer plans were involved in 524,052 disputes, a 119% increase from...
Apr 6, 2026 | Emergency Room (ER), Food and Drug Administration (FDA), Government, News, Over-the-counter (OTC) drugs, Survey, Urgent Care
FDA Commissioner Marty Makary, MD, MPH, made expanding over-the-counter (OTC) availability of more drugs a clear priority during an April 1, 2026 press conference. “When I look at the reasons those drugs were not approved in the past, I think we can do better,” he...
